<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>01459nam a22001937a 4500</leader>
  <controlfield tag="001">9468</controlfield>
  <controlfield tag="003">OCLRC</controlfield>
  <controlfield tag="005">20260730103744.0</controlfield>
  <controlfield tag="008">210505t        xxu||||| |||| 00| 0 eng d</controlfield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="a">OCLRC</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Pinfield, S. </subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Medical research charities and open access/</subfield>
    <subfield code="c">S. Pinfield. </subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="a">2013.</subfield>
  </datafield>
  <datafield tag="500" ind1=" " ind2=" ">
    <subfield code="a">10.1087/20130409 </subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">This paper provides an analysis of the attitudes and activities of UK medical research charities in relation to open access (OA). Both quantitative and qualitative data are presented derived from a recent survey of charities covering areas such as policy development, funding arrangements, and business process design for OA. Positions on key issues including green and gold OA, funding article-processing charges (APCs), and publication licences are assessed. Modelling of potential APCs as a percentage of overall annual research spend is undertaken to show possible costs of a charged for gold system. Medical research charities clearly regard OA as important and some see it as an opportunity to further their mission. However, many expressed significant concerns particularly about the costs and expertise required to support OA. Further co-ordination of policy development and action across the sector and with other stakeholders is recommended in order to help ensure optimal implementation of OA.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">medical research, </subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">open access,</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="c">ELEC</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">9468</subfield>
    <subfield code="d">9468</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="0">0</subfield>
    <subfield code="1">0</subfield>
    <subfield code="4">0</subfield>
    <subfield code="7">0</subfield>
    <subfield code="a">LRC</subfield>
    <subfield code="b">LRC</subfield>
    <subfield code="d">2026-07-30</subfield>
    <subfield code="l">0</subfield>
    <subfield code="r">2026-07-30 10:37:44</subfield>
    <subfield code="w">2026-07-30</subfield>
    <subfield code="y">ELEC</subfield>
  </datafield>
</record>
